3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
7
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
GATA2 Deficiency
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
BRCA1 Mutation
1
Anemia, Refractory, with Excess of Blasts
1
Allogeneic Stem Cell Transplantation
1
Interventions
Cyclophosphamide
16
Rituximab
14
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
fludarabine phosphate
7
fludarabine
7
Specimen Handling
7
Prednisone
7
Etoposide
6
Biopsy
6
tocilizumab
5
polatuzumab vedotin
5
ibrutinib
5
X-Rays
5
Whole-Body Irradiation
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Melphalan
5
Lenalidomide
5
Doxorubicin
5
Mycophenolic Acid
4
Cytarabine
4
Cyclosporine
4
Busulfan
4
venetoclax
3
pembrolizumab
3
glofitamab
3
acalabrutinib
3
Vincristine
3
Tacrolimus
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
decitabine and cedazuridine drug combination
×
30 days
×
Clear all
No trials found.